Disclaimer
Please note that the following pages are exclusively reserved for health care professionals in countries with applicable health authority product registrations. To the extent this site contains information, reference guides and databases intended for use by licensed medical professionals, such materials are not intended to offer professional medical advice. Prior to use, please consult device labeling for prescriptive information and operating instructions.
US: CAUTION – Investigational Device. Limited by Federal (or United States) law to investigational use.
Videos
A Forward Outlook on TAVR for Aortic Regurgitation
This session takes a look at the future of TAVR for aortic regurgitation, examining the imaging challenges of AR evaluation, how the JenaValve Trilogy System and the ALIGN-AR Study may offer a dedicated TAVR solution for AR, and the real-world experience with the Trilogy System in the EU. The discussion is moderated by Drs. Hendrik Treede and Sam Dawkins, and features presentations from Drs. Vera Rigolin, Raj Makkar, and Matti Adam.
Latest News
View All
Press
April 1, 2026
JenaValve Announces Start of Commercialization of the Trilogy® Transcatheter Heart Valve System in the US
Read More
Press
March 18, 2026
JenaValve Announces FDA Approval of the Trilogy™ Transcatheter Heart Valve System
Read More
Press
November 24, 2025
New, Late-Breaking Results from the ALIGN-AR Trial Published in The Lancet and Presented at PCR London Valves
Read More